Published in Radiother Oncol on September 19, 2007
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol (2005) 4.68
Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys (2007) 3.38
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol (2011) 2.85
Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys (2011) 2.48
Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol (2007) 2.26
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol (2007) 2.18
Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys (2010) 2.05
Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol (2006) 1.94
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol (2010) 1.75
Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). Int J Radiat Oncol Biol Phys (2005) 1.75
Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol (2009) 1.70
Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys (2009) 1.68
Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol (2006) 1.60
GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol (2009) 1.60
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy (2012) 1.57
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys (2006) 1.54
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol (2012) 1.54
Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. Radiother Oncol (2010) 1.39
Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy. Radiother Oncol (2013) 1.39
Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction. Radiother Oncol (2012) 1.19
Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys (2007) 1.19
Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol (2009) 1.19
Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol (2008) 1.18
Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol (2008) 1.17
Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol (2008) 1.15
Direct reconstruction of the Vienna applicator on MR images. Radiother Oncol (2009) 1.15
Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol (2010) 1.12
Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol (2010) 1.11
Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Int J Radiat Oncol Biol Phys (2011) 1.09
Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2005) 1.09
Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol (2008) 1.07
Uncertainties in image guided adaptive cervix cancer brachytherapy: impact on planning and prescription. Radiother Oncol (2013) 1.07
Accuracy of volume and DVH parameters determined with different brachytherapy treatment planning systems. Radiother Oncol (2007) 1.07
Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study. Radiother Oncol (2013) 1.01
Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol (2006) 1.00
Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys (2008) 0.99
New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame. Radiother Oncol (2009) 0.99
Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. Radiother Oncol (2010) 0.96
Application of commercial MOSFET detectors for in vivo dosimetry in the therapeutic x-ray range from 80 kV to 250 kV. Phys Med Biol (2005) 0.96
Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol (2006) 0.95
A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy. Radiother Oncol (2013) 0.94
Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis. Radiother Oncol (2011) 0.94
Late gastrointestinal and urogenital side-effects after radiotherapy--incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer. Radiother Oncol (2012) 0.93
Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol (2005) 0.91
Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study. Radiother Oncol (2013) 0.91
Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses. Radiother Oncol (2010) 0.91
Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: assessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance. Radiother Oncol (2013) 0.91
Radiation caries--radiogenic destruction of dental collagen. Oral Oncol (2005) 0.90
Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy. Strahlenther Onkol (2009) 0.89
Comparison of CT- and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software. Strahlenther Onkol (2006) 0.88
Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol (2006) 0.87
Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe. Radiother Oncol (2006) 0.85
PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy. Radiother Oncol (2010) 0.85
Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy. Brachytherapy (2008) 0.85
Second primary cancers after radiation for prostate cancer: a review of data from planning studies. Radiat Oncol (2013) 0.85
Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy. Brachytherapy (2005) 0.84
Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy. Acta Oncol (2013) 0.83
Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children. Strahlenther Onkol (2009) 0.82
Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int J Radiat Oncol Biol Phys (2007) 0.80
Three-dimensional reconstruction of seed implants by randomized rounding and visual evaluation. Med Phys (2007) 0.80
Imaging of implant needles for real-time HDR-brachytherapy prostate treatment using biplane ultrasound transducers. Med Phys (2009) 0.79
A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes. J Appl Clin Med Phys (2016) 0.78
The design and testing of a solid phantom for the verification of a commercial 3D seed reconstruction algorithm. Radiother Oncol (2004) 0.78
Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Strahlenther Onkol (2004) 0.77
Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Coll Cardiol (2002) 0.77
Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom. Radiother Oncol (2006) 0.77
High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Strahlenther Onkol (2006) 0.76
Partial-breast irradiation or whole-breast radiotherapy for early breast cancer: a meta-analysis of randomized trials. Strahlenther Onkol (2010) 0.76
Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base. Strahlenther Onkol (2005) 0.76
3D-conformal radiotherapy for prevention of carotid recurrent in-stent restenosis. Initial experience. Wien Klin Wochenschr (2005) 0.76
In reply A. Sharma et al. Int J Radiat Oncol Biol Phys (2013) 0.75
Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients. Radiother Oncol (2012) 0.75
Image-guided treatment planning in brachytherapy for cervical cancer. In regard to Kubicky et al (Brachytherapy 2008;7:242-247). Brachytherapy (2008) 0.75
A dosimetric analysis of interstitial intensity modulated implants for pelvic recurrences, base of tongue and orbita tumors with specific references to the ICRU-58. Radiother Oncol (2006) 0.75
A rare desmoid tumor of the shoulder--excision, implantation of brachytherapy applicators and wound closure by pedicle musculus latissimus dorsi flap. Ger Med Sci (2011) 0.75
Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. Radiother Oncol (2005) 0.75
Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169. Radiat Prot Dosimetry (2005) 0.75
[New irradiation method in breast cancer. What is the value of brachytherapy? (interview by Erik Heintz)]. MMW Fortschr Med (2003) 0.75
Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease. Cardiovasc Revasc Med (2009) 0.75
Increased dosage during intracoronary irradiation due to overlapped source stepping shows no long-term adverse changes in vessel morphology. J Interv Cardiol (2004) 0.75
Dose to the non-involved uterine corpus with MRI guided brachytherapy in locally advanced cervical cancer. Radiother Oncol (2013) 0.75
Co-operative bidding of SMEs in health care sector. Stud Health Technol Inform (2002) 0.75
Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis. Coron Artery Dis (2004) 0.75
Vascular morphometric changes after radioactive stent implantation: a dose-response analysis. J Am Coll Cardiol (2002) 0.75
Preliminary results of a comparison between high-tech external beam and high-tech brachytherapy for cervix carcinoma. Strahlenther Onkol (2007) 0.75
CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy. Brachytherapy (2013) 0.75
Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. Radiother Oncol (2002) 0.75
Present status of endovascular brachytherapy in peripheral arteries. Herz (2002) 0.75
Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss. Radiother Oncol (2004) 0.75